Browse by author
Lookup NU author(s): Helen Spencer, Professor Douglas Turkington, Dr Rob DudleyORCiD
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
© 2018 Elsevier B.V. This study investigated the effect of “dose” and the components of Cognitive Behavioral Therapy (CBT) on treatment effects. It is a secondary analysis of the ACTION (Assessment of Cognitive Therapy Instead of Neuroleptics) trial which investigated CBT for people with schizophrenia spectrum disorders that chose not to take antipsychotic medication. Using instrumental variable methods, we found a “dose-response” such that each CBT session attended, reduced the primary outcome measure (the PANSS total score) by approximately 0.6 points (95% CI −1.20 to −0.06, p = 0.031). This suggests that length of therapy is important for those that receive CBT in the absence of antipsychotic medication. Secondly, using principal stratification we examined the process variables that modified treatment effects. Findings revealed that those who received a longitudinal formulation in the first 4 sessions of CBT had poorer treatment effects than those who did not, however this finding was not statistically significant (95% CI −37.244, 6.677, p = 0.173). However, it is important to note that these findings were evident in an exploratory analysis with a small sample. Future larger scale studies are needed to help understand components of effective treatment.
Author(s): Spencer HM, McMenamin M, Emsley R, Turkington D, Dunn G, Morrison AP, Brabban A, Hutton P, Dudley R
Publication type: Article
Publication status: Published
Journal: Schizophrenia Research
Year: 2018
Volume: 202
Pages: 385-386
Print publication date: 01/12/2018
Online publication date: 12/07/2018
Acceptance date: 03/07/2018
ISSN (print): 0920-9964
ISSN (electronic): 1573-2509
Publisher: Elsevier BV
URL: https://doi.org/10.1016/j.schres.2018.07.016
DOI: 10.1016/j.schres.2018.07.016
Altmetrics provided by Altmetric
